News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines By Yael L. Maxwell September 03, 2025
Presentation TCT 2024 Patient-Reported Outcomes are a True Measure of TTVI Value Presenter: John A. Spertus October 30, 2024
Presentation TCT 2024 TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation Presenter: Susheel K. Kodali October 30, 2024
Presentation TCT 2024 How to Interpret Patient Reported Outcomes (PROs): Lessons from the Regulatory Approval Trials in TTVI Presenter: Suzanne V. Arnold October 30, 2024
Presentation TCT 2024 Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned? Presenter: Brian K. Whisenant October 30, 2024
Presentation TCT 2024 Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II Presenter: Charles J. Davidson October 30, 2024
Presentation TCT 2024 TCT 983: Innovative Approach to Right Sided Endocarditis Presenter: Bahjat Aladili October 30, 2024